This document discusses brucellosis, a zoonotic disease caused by bacteria of the genus Brucella. It primarily affects livestock such as cattle, goats, and pigs. The disease can be transmitted to humans through consumption of unpasteurized dairy products or contact with infected animals/tissues. Clinical features in humans include undulant fever and nonspecific symptoms affecting multiple organ systems. Diagnosis involves serological tests or culture of blood/tissues. Treatment consists of a combination of doxycycline and streptomycin or rifampin over several weeks. Prevention focuses on vaccination of livestock and avoiding raw dairy products.
Brucellosis is an important re-emerging zoonosis with a worldwide distribution, in India was recognised first in 1942.
It is still an uncontrolled serious public health problem in many developing countries including India. Brucellosis in India is yet a very common but often neglected disease.
Brucellosis is an important re-emerging zoonosis with a worldwide distribution, in India was recognised first in 1942.
It is still an uncontrolled serious public health problem in many developing countries including India. Brucellosis in India is yet a very common but often neglected disease.
Zoonotic disease caused by Bacillus anthracis
Infects primarily herbivores- goats, sheep, cattle, horses and swine
Human infections - contact with infected animals or contaminated animal products
Human infections rarely via the respiratory or gastrointestinal tracts
Zoonotic disease caused by Bacillus anthracis
Infects primarily herbivores- goats, sheep, cattle, horses and swine
Human infections - contact with infected animals or contaminated animal products
Human infections rarely via the respiratory or gastrointestinal tracts
Descripción de la brucelosis en Argentina, una mirada de la brucelosis humana con el impacto que lleva la brucelosis animal en ella, diagnóstico médico, microbiológico y tratamiento.
Brucellosis, a bacterial disease caused by members of the genus Brucella, is an important zoonosis and a significant cause of reproductive losses in animals.
Class Presentation of Master of Science in Medical Microbiology 2nd semester at Institute of Science and Technology, Tribhuvan University.
Brocellosis disease is a zoonotic infection caused by Breculla spp and transmitted to humans by contact with fluids from infected domestic animal (sheep,goats, cattle,pigs and other animals)
Brucellosis also called Bang's disease, malta fever, Mediterranean fever or Undulunt fever
Brucellosis is an enzootic infection (i.e. endemic in animal) caused by Gram-negative bacilli.
Infected animals may excrete Brucella spp, in their milk for prolonged periods and human infection is acquired by ingesting contaminated dairy products (especially unpasteurised milk), uncooked meat or offal.
Animal urine, faeces, vaginal discharge and uterine products may transmit infection through abraded skin or via splashes and aerosols to the respiratory tract and conjunctiva.
Brucellosis is an enzootic infection (i.e. endemic in animal) caused by Gram-negative bacilli.
Infected animals may excrete Brucella spp, in their milk for prolonged periods and human infection is acquired by ingesting contaminated dairy products (especially unpasteurised milk), uncooked meat or offal.
Animal urine, faeces, vaginal discharge and uterine products may transmit infection through abraded skin or via splashes and aerosols to the respiratory tract and conjunctiva.
Brucellosis is an enzootic infection (i.e. endemic in animal) caused by Gram-negative bacilli.
Infected animals may excrete Brucella spp, in their milk for prolonged periods and human infection is acquired by ingesting contaminated dairy products (especially unpasteurised milk), uncooked meat or offal.
Animal urine, faeces, vaginal discharge and uterine products may transmit infection through abraded skin or via splashes and aerosols to the respiratory tract and conjunctiva.
Brucellosis is an enzootic infection (i.e. endemic in animal) caused by Gram-negative bacilli.
Infected animals may excrete Brucella spp, in their milk for prolonged periods and human infection is acquired by ingesting contaminated dairy products (especially unpasteurised milk), uncooked meat or offal.
Animal urine, faeces, vaginal discharge and uterine products may transmit infection through abraded skin or via splashes and aerosols to the respiratory tract and conjunctiva.
Brucellosis is an enzootic infection (i.e. endemic in animal) caused by Gram-negative bacilli.
Infected animals may excrete Brucella spp, in their milk for prolonged periods and human infection is acquired by ingesting contaminated dairy products (especially unpasteurised milk), uncooked meat or offal.
Animal urine, faeces, vaginal discharge and uterine products may transmit infection through abraded skin or via splashes and aerosols to the respiratory tract and conjunctiva.
Toxoplasmosis is considered one of the neglected parasitic infections of the United States, a group of five parasitic diseases that have been targeted by CDC for public health action.Q fever is a disease caused by the bacteria Coxiella burnetii. This bacteria naturally infects some animals, such as goats, sheep, and cattle. C. burnetii bacteria are found in the birth products (i.e. placenta, amniotic fluid), urine, feces, and milk of infected animals.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
2. Objectives
Students should be able to:
• Define brucellosis.
• Describe the causative organism.
• Describe pathogenesis and clinical features of the disease.
• Mention diagnostic methods of brucellosis.
• State treatment of brucellosis.
• Describe prevention and control of the disease.
4. Brucellosis
o Brucellosis is a zoonosis primarily of
domestic animals, causing a chronic
debilitating septicemic disease leading to
abortion.
o The disease is prevalent worldwide and is
particularly common in the Mediterranean
and Middle Eastern countries, and in parts of
Africa and South America.
5. Other Names of Human
Brucellosis
o Malta Fever, Undulant Fever, Mediterranean
Fever, Gastric Fever.
o The causal Brucella species are named after
Sir David Bruce, who discovered the cause of
one form of the disease while serving in
Malta in 1887.
10. Antigenic Structure and Classification
o A and M antigens are common to 3 mains
Brucella spp.
o B. melitensis has the highest concentration of
M antigen and causes the most serious
infections.
o The difference between species is related to
the amount of the two main antigen:
11. • B. abortus : A:M=20:1
• B. melitensis: A:M=1:20
• B. suis : A:M=2:1
Antigenic Structure and Classification
AA MM
AA MM
MMAA
13. Pathogenesis
o Ingestion:
• Raw milk & unpasteurized dairy products.
• Rarely through undercooked meat.
o Inhalation:
o Inoculation:
o Person-to-person transmission is very rare.
of placental or uterine discharges, blood
and urine.
14. Pathogenesis
o Animal tissues and products, such as
placenta, uterus and milk, that are rich in
erythritol (a growth factor for brucellae) can
be heavily contaminated and highly
infectious.
o Spread in the body occurs via lymphatics,
replication within lymph nodes, and then wide
hematogenous spread to organs and tissues.
16. Who is at Risk?
o Occupational Disease:
• Cattle ranchers/dairy farmers.
• Veterinarians.
• Abattoir workers.
• Meat inspectors.
• Lab workers.
o Hunters.
o Travelers.
o Consumers of unpasteurized dairy products.
18. Clinical features
o Incubation period: 1-3 weeks,
occasionally several months.
o Can affect any organ or organ system.
o Fever may be intermittent or undulant.
Fever, often persists for months or
years. Undulant fever
39.5
37.0
19. Clinical features
o Non specific symptoms: sweating,
anorexia, constipation, rigor and
weakness.
o Depression.
o Osteoarticular complications e.g. arthritis,
osteomyelitis.
20. Clinical features
o Splenomegaly, lymphadenopathy and
hepatomegaly.
o Orchitis and epididymitis.
o A septicemic disease, abortion can occur.
23. Diagnosis
1- Clinical features.
2- Serology: brucella agglutinins in the blood.
3- Blood or tissue culture.
4- Polymerase Chain Reaction (PCR).
24. Diagnosis in Humans
o Serology: brucella agglutination test.
• Four-fold or greater rise in titer.
• Samples 2 weeks apart.
o BAT detects antibody to B. abortus, B.
melitensis and B. suis but NOT to B. canis.
o Therefore, specific serologic tests for B.
Canis must be requested.
o Rose Bengal Test is useful for screening.
26. Diagnosis in Humans
o False positive: cross reactivity with
antibodies of F. tularensis,, E. coli and V.
cholerae.
o False negative: in prozone phenomenon.
27. Diagnosis in Humans
o Prozone phenomenon may occur secondarily
to hyperantigenemia, which might result in a
false-negative results.
o High levels of antigen may prevent the
formation of antigen-antibody complexes.
o To solve this problem, routine dilution of the
serum beyond 1:320 would help to prevent
such a problem.
28. o 2-ME-test (mercaptoethanol): more specific,
positive in chronic Brucellosis.
o ELISA test:
• High IgM in acute infection.
• High IgG in chronic infection.
Diagnosis in Humans
29. Diagnosis in Humans
o Culture of blood, bone marrow and tissue fluids.
• Blood culture: +ve in about 50 -70% of
cases.
• Bone marrow culture is the standard criterion,
since the reticuloendothelial system holds a
high concentration of the organism.
Sensitivity 80-90%.
• Blood or bone cultures should be incubated
for at least 6 weeks.
30. o PCR is a rapid and accurate method for
diagnosis of Brucella species.
o CBC: Non specific, (leucopenia, lymphocytosis,
anemia). Moderate elevation of ESR.
Diagnosis in Humans
32. Treatment of Choice
o Combination therapy has the best efficacy.
• Doxycycline for six weeks in
combination with streptomycin for 2-3
weeks or rifampicin for 6 weeks.
o CNS cases treat 6-9 months.
• Same for endocarditis cases plus
surgical replacement of valves.
33. Prognosis
o This disease is easily curable with a low
risk of relapse or chronicity.
o About 5% of treated cases relapse
• Failure to complete the treatment
regimen
34. Prevention and Control
o Education about risk of transmission.
• Farmer, veterinarian, abattoir worker,
butcher, etc.
o Wear proper attire if dealing with infected
animals/tissues.
• Gloves, masks, goggles.
o Avoid consumption of raw dairy products.
35. Prevention and Control
o Immunize animals in areas of high
prevalence.
• Effective attenuated live bacterial vaccines
exist against B. abortus (strain 19) and B.
melitesis (Rev-I), but as yet none exists
for B. suis or B. canis.
o No human vaccine.